Centre intégré universitaire de santé et de services sociaux de l’Ouest-de-l’Île-de-Montréal
Accueil Plan du site Courrier Portail Québec Passer directement au contenu

Claire-Dominique Walker, PhD
Photo

Director, Neuroscience Research Division, Douglas Institute
Researcher, Douglas Institute
Full Professor, Department of Psychiatry, and Department of Anatomy & Cell Biology, McGill University


dominique_dot_walker_At_douglas_dot_mcgill_dot_ca
Publications

2001

Proulx K., Clavel S., Nault G., Richard D., Walker C. (2001). High neonatal leptin exposure enhances brain GR expression and feedback efficacy on the adrenocortical axis of developing rats, Endocrinology, 142(11), 4607-16.

Van Ameringen M. A., Lane R. M., Walker C., Bowen R. C., Chokka P. R., Goldner E. M., Johnston D. G., Lavallee Y. J., Nandy S., Pecknold J. C., Hadrava V., Swinson R. P. (2001). Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study, Am J Psychiatry, 158(2), 275-81.

Walker C., Anand K. J. S., Plotsky P. M. (2001). Development of the Hypothalamus-Pituitary-Adrenal Axis and the Stress Response . In McEwen B. S. (Ed.) , Handbook of Physiology - Section 7: The Endocrine System. Volume IV: Coping with the Environment: Neural and Endocrine Mechanisms (pp. 237-270). Oxford University Press.

Walker C., Tilders F. J., Burlet A. (2001). Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry, J Neuroendocrinol, 13(1), 74-85.

Walker C., Toufexis D. J., Burlet A. (2001). Hypothalamic and limbic expression of CRF and vasopressin during lactation: implications for the control of ACTH secretion and stress hyporesponsiveness, Prog Brain Res, 133, 99-110.

Xu Y. C., Johnson K. W., Phebus L. A., Cohen M., Nelson D. L., Schenck K., Walker C., Fritz J. E., Kaldor S. W., LeTourneau M. E., Murff R. E., Zgombick J. M., Calligaro D. O., Audia J. E., Schaus J. M. (2001). N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy, J Med Chem, 44(24), 4031-4.

<< Back to Claire-Dominique Walker 's profile
Sort by :
By year :
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001

[+] view more

Awards and distinctions :
  • - CCNP Young Investigator Award
[ view more awards ]
Neurophenotyping Center inauguration (in French)
path
send
share
share